Haploidentical Bone Marrow Transplantation With Clofarabine and Busulfan Conditioning for a Child With Multiple Recurrent Acute Lymphoblastic Leukemia
Authors:
- Reiji MiyawakiRMReiji Miyawaki
- Kohsuke ImaiKIKohsuke Imai
- Masatoshi TakagiMTMasatoshi Takagi
- Michiko KajiwaraMKMichiko Kajiwara
- Yasuyoshi IshiwataYIYasuyoshi Ishiwata
- Masato YasuharaMYMasato Yasuhara
- Tomohiro MorioTMTomohiro Morio
- Shuki MizutaniSMShuki Mizutani
- Daisuke TomizawaDTDaisuke Tomizawa
- 1 January 2016
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 38 (1) , e39-e41
Abstract
Outcome of children with acute lymphoblastic leukemia (ALL) has improved over the years, but not for those with multiple recurrences because of high therapy resistance and heavily pretreated history that potentially cause physical damages. We describe the case of an 11-year-old boy with a third relapse of ALL and a history of 2 allogeneic bone marrow transplantations. He was successfully treated with clofarabine combination chemotherapy and achieved a fourth remission at 16 months following haploidentical bone marrow transplantation with conditioning regimen of clofarabine and busulfan. Clofarabine/busulfan conditioning might be a preferable option for children with multiple recurrent ALL, and warrants further investigation.Keywords
This publication has 19 references indexed in Scilit:
- Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2012
- Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMTEuropean Journal of Haematology, 2012
- Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemiaBlood, 2011
- Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesBlood, 2011
- Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantationBlood, 2010
- Clofarabine, cyclophosphamide and etoposide as single‐course re‐induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemiaBritish Journal of Haematology, 2009
- Loss of Mismatched HLA in Leukemia after Stem-Cell TransplantationNew England Journal of Medicine, 2009
- Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15Haematologica, 2008
- Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2006
- Childhood acute lymphoblastic leukaemia and relapseBritish Journal of Haematology, 2005